| Literature DB >> 30564902 |
Keiko Sugai1, Takehiro Michikawa2, Toru Takebayashi3, Morio Matsumoto1, Masaya Nakamura1, Yuji Nishiwaki4.
Abstract
This cohort study conducted in Japan showed that severe age-related kyphosis was visually detected. The visual assessment of kyphosis was associated with declines in ADL, suggesting that we can easily identify people at high risk to develop future ADL reduction in the community setting.Entities:
Keywords: Activity of daily living; Cohort study; Kyphosis; Visual assessment
Mesh:
Year: 2018 PMID: 30564902 PMCID: PMC6299049 DOI: 10.1007/s11657-018-0551-4
Source DB: PubMed Journal: Arch Osteoporos Impact factor: 2.617
Fig. 1Pictures used for reference in the visual classification of kyphosis (these were drawn from photographs, but the originals were not used so as to protect the privacy of the patients)
Baseline characteristics of the participants in the four kyphosis groups as assessed by the representative rater (n = 532)
| Kyphosis category | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||||||
| Age category | |||||||||
| 65–69 years | 54 | (55.1) | 47 | (16.0) | 4 | (3.8) | 0 | (0.0) | |
| 70–74 years | 29 | (29.6) | 75 | (25.5) | 18 | (17.1) | 0 | (0.0) | |
| 75–79 years | 12 | (12.2) | 107 | (36.4) | 24 | (22.9) | 7 | (20.0) | |
| 80 years | 3 | (3.1) | 65 | (22.1) | 59 | (56.1) | 28 | (80.0) | < 0.001 |
| Sex | |||||||||
| Female | 64 | (65.3) | 135 | (45.9) | 65 | (61.9) | 26 | (74.3) | < 0.001 |
| Body mass index (BMI)† | 22.8 ± 3.4 | 22.9 ± 3.0 | 22.5 ± 3.3 | 21.6 ± 3.4 | |||||
| BMI < 18.5 | 4 | (8.7) | 8 | (3.7) | 10 | (11.0) | 6 | (18.8) | |
| 18.5 =< BMI < 25.0 | 31 | (67.4) | 133 | (61.9) | 59 | (64.8) | 21 | (65.6) | |
| 25.0 =< BMI | 11 | (23.9) | 74 | (34.4) | 22 | (24.2) | 5 | (15.6) | 0.010 |
| Current smoking | |||||||||
| Yes | 9 | (9.2) | 35 | (11.9) | 10 | (9.5) | 2 | (5.7) | 0.625 |
| Current drinking | |||||||||
| Yes | 36 | (36.7) | 118 | (40.1) | 30 | (28.6) | 3 | (8.6) | 0.001 |
| Hearing handicap⁑ | |||||||||
| Yes | 13 | (13.3) | 82 | (27.9) | 38 | (36.2) | 15 | (42.9) | < 0.001 |
| Measured vision impairment§ | |||||||||
| Impaired | 89 | (90.8) | 252 | (85.7) | 74 | (70.5) | 24 | (68.6) | < 0.001 |
| Education** | |||||||||
| High school or higher | 26 | (45.6) | 71 | (28.9) | 20 | (20.8) | 4 | (12.5) | 0.002 |
| Marital status** | |||||||||
| Married$ | 48 | (85.7) | 189 | (76.5) | 75 | (78.9) | 16 | (51.6) | 0.003 |
| History of life-threatening diseases∥ | |||||||||
| Yes | 74 | (75.5) | 203 | (69.1) | 82 | (78.1) | 25 | (71.4) | 0.282 |
| Knee joint pain | |||||||||
| Always | 1 | (1.0) | 26 | (8.8) | 15 | (14.3) | 5 | (14.3) | |
| Often | 14 | (14.3) | 30 | (10.2) | 16 | (15.2) | 3 | (8.6) | |
| Occasionally | 25 | (25.5) | 89 | (30.3) | 26 | (24.8) | 7 | (20.0) | |
| Never | 58 | (59.2) | 149 | (50.7) | 48 | (45.7) | 20 | (57.1) | 0.035 |
| Back pain | |||||||||
| Always | 7 | (7.1) | 35 | (11.9) | 24 | (22.9) | 14 | (40.0) | |
| Often | 10 | (10.2) | 28 | (9.5) | 21 | (20.0) | 4 | (11.4) | |
| Occasionally | 27 | (27.6) | 94 | (32.0) | 35 | (33.3) | 8 | (22.9) | |
| Never | 54 | (55.1) | 137 | (46.6) | 25 | (23.8) | 9 | (25.7) | < 0.001 |
| Current depressive symptom¶ | |||||||||
| GDS5 0–1 | 72 | (73.5) | 174 | (59.2) | 48 | (45.7) | 10 | (28.6) | |
| GDS5 >= 2 | 26 | (26.5) | 120 | (40.8) | 57 | (54.3) | 25 | (71.4) | < 0.001 |
| Bone stiffness | |||||||||
| Q1 | 8 | (8.2) | 59 | (20.1) | 37 | (35.2) | 23 | (65.7) | |
| Q2 | 17 | (17.3) | 83 | (28.2) | 29 | (27.6) | 6 | (17.1) | |
| Q3 | 24 | (24.5) | 80 | (27.2) | 21 | (20.0) | 4 | (11.4) | |
| Q4 | 49 | (50.0) | 72 | (24.5) | 18 | (17.1) | 2 | (5.7) | < 0.001 |
| Occiput to table distance | |||||||||
| 0–2 | 96 | (98.0) | 239 | (81.3) | 49 | (47.1) | 17 | (48.6) | |
| 3 | 2 | (2.0) | 36 | (12.2) | 29 | (28.9) | 3 | (8.6) | |
| 4 | 0 | (0.0) | 16 | (5.4) | 15 | (14.4) | 2 | (5.7) | |
| 5-maximum | 0 | (0.0) | 3 | (1.0) | 11 | (10.6) | 13 | (37.1) | < 0.001 |
| Kyphosis index | |||||||||
| Q1 | 42 | (42.9) | 74 | (25.1) | 14 | (13.3) | 1 | (2.9) | |
| Q2 | 33 | (33.7) | 85 | (28.9) | 13 | (12.4) | 2 | (5.7) | |
| Q3 | 17 | (17.4) | 76 | (25.9) | 28 | (26.7) | 7 | (20.0) | |
| Q4 | 6 | (6.1) | 59 | (20.1) | 50 | (47.6) | 25 | (71.4) | < 0.001 |
| Inclination measured by Spinal Mouse | |||||||||
| Q1 | 45 | (45.9) | 60 | (20.4) | 10 | (9.5) | 1 | (2.8) | |
| Q2 | 32 | (32.7) | 95 | (32.3) | 12 | (11.4) | 0 | (0.0) | |
| Q3 | 20 | (20.4) | 90 | (30.6) | 20 | (19.5) | 3 | (8.6) | |
| Q4 | 1 | (1.0) | 49 | (16.7) | 63 | (60.0) | 31 | (88.6) | < 0.001 |
*Due to some missing values, the totals for the stratified subgroups are not equal. †Body mass index was calculated as weight (kg) divided by the square of height (m), as predicted by the demispan. ⁑Hearing handicap Inventory for the Elderly Screening scores of 10 or more were considered to indicate hearing handicap. Corrected distance visual acuity worse than 0.5 in the better eye. **Answered in the questionnaire used in 2005–2006. ∥Past or current history of major illness: stroke, coronary heart disease, diabetes mellitus, cancer. ¶Depressive symptoms were defined as scores of 2 or more on the five-item version of the Geriatric Depression Scale. #Chi-square test or Fisher’s exact test. $Widowed, divorced, or single persons are not recorded as Married
Adjusted risk ratios of ADL decline by kyphosis category as assessed by the representative rater
| Outcome | Kyphosis category | Outcome | Age and sex adjusted RR† | 95% CI⁑ | Model 1§ RR† | 95% CI⁑ | Model 2∥ RR † | 95% CI⁑ | |
|---|---|---|---|---|---|---|---|---|---|
| % | |||||||||
| Combined ADL decline* | 1 | 7/93 | 7.5 | 0.7 | 0.3–1.5 | 0.9 | 0.4–2.5 | 1.0 | 0.4–2.7 |
| 2 | 44/270 | 16.3 | 1.0 | – | 1.0 | – | 1.0 | – | |
| 3 | 35/92 | 38.0 | 1.9 | 1.3–2.9 | 2.1 | 1.3–3.2 | 1.9 | 1.2–2.9 | |
| 4 | 20/30 | 66.7 | 3.0 | 1.9–4.7 | 3.1 | 1.8–5.3 | 2.6 | 1.4–4.6 | |
| Katz ADL decline* | 1 | 2/93 | 2.2 | 0.4 | 0.1–1.6 | 0.5 | 0.1–4.0 | 0.5 | 0.1–4.1 |
| 2 | 24/270 | 8.9 | 1.0 | – | 1.0 | – | 1.0 | – | |
| 3 | 21/92 | 22.8 | 2.1 | 1.2–3.7 | 2.5 | 1.3–4.6 | 2.2 | 1.2–4.1 | |
| 4 | 16/30 | 53.3 | 4.4 | 2.4–8.1 | 4.6 | 2.1–9.8 | 3.8 | 1.7–8.7 | |
| Admission to nursing home* | 1 | 1/93 | 1.1 | 0.4 | 0.0–3.1 | 0.0 | -# | 0.0 | -# |
| 2 | 7/270 | 2.6 | 1.0 | – | 1.0 | – | 1.0 | – | |
| 3 | 9/92 | 9.8 | 3.1 | 1.2–7.7 | 3.8 | 1.2–11.7 | 4.8 | ||
| 4 | 4/30 | 13.3 | 3.6 | 1.1–11.7 | 4.1 | 1.5–11.7 | 4.8 | ||
| Need of assistance at home* | 1 | 6/93 | 6.5 | 0.8 | 0.3–2.0 | 1.2 | 0.4–3.2 | 1.2 | 0.5–3.3 |
| 2 | 32/270 | 11.9 | 1.0 | – | 1.0 | – | 1.0 | – | |
| 3 | 29/92 | 31.5 | 2.1 | 1.4–3.4 | 2.3 | 1.4–4.0 | 2.2 | 1.3–3.7 | |
| 4 | 18/30 | 60.0 | 3.6 | 2.2–6.0 | 3.7 | 2.0–6.7 | 3.2 | 1.6–6.2 | |
| Death | 1 | 5/98 | 5.1 | 1.0 | 0.4–2.8 | 1.0 | 0.2–4.6 | 1.2 | 0.3–5.4 |
| 2 | 24/294 | 8.2 | 1.0 | – | 1.0 | – | 1.0 | – | |
| 3 | 13/105 | 12.4 | 1.2 | 0.6–2.3 | 1.2 | 0.5–2.7 | 1.4 | 0.6–3.2 | |
| 4 | 5/35 | 14.3 | 1.2 | 0.4–3.2 | 0.9 | 0.2–3.3 | 1.0 | 0.1–3.9 | |
*Participants who died during the follow-up period (n = 47) were excluded from the analysis. †RR risk ratio. ⁑CI confidence interval. §Adjusted for age category, sex, marital status, education, drinking, smoking, BMI, vision impairment, hearing handicap, knee joint pain, depressive symptoms, and history of life-threatening diseases (stroke, coronary heart disease, diabetes mellitus, cancer). ∥In addition to the variables adjusted in Model 1, back pain, and bone stiffness category are included. #Due to a lack of outcome data, statistical computation was impossible
Adjusted risk ratios of “Combined ADL decline” as assessed with a conventional method of kyphosis assessment
| Kyphotic measures | Combined ADL decline* | Age and sex adjusted RR† | 95% CI⁑ | Model 1§ RR† | 95% CI⁑ | Model 2∥ RR † | 95% CI⁑ | ||
|---|---|---|---|---|---|---|---|---|---|
| % | |||||||||
| Kyphosis index | Q1 | 27/123 | 22.0 | 1.4 | 0.8–2.3 | 1.4 | 0.7–2.6 | 1.3 | 0.7–2.5 |
| Q2 | 19/111 | 17.1 | 1.0 | – | 1.0 | – | 1.0 | – | |
| Q3 | 20/129 | 15.5 | 1.0 | 0.6–1.8 | 0.9 | 0.4–1.7 | 0.8 | 0.4–1.7 | |
| Q4 | 40/122 | 32.8 | 1.7 | 1.0–2.7 | 1.6 | 0.9–2.8 | 1.5 | 0.8–2.7 | |
| Inclination | Q1 | 14/112 | 12.5 | 1.7 | 0.8–3.5 | 1.1 | 0.4–2.7 | 1.2 | 0.5–2.9 |
| Q2 | 11/127 | 8.7 | 1.0 | – | 1.0 | – | 1.0 | – | |
| Q3 | 26/120 | 21.7 | 2.4 | 1.2–4.5 | 2.1 | 1.1–4.2 | 2.1 | 1.0–4.1 | |
| Q4 | 55/126 | 43.7 | 3.7 | 2.0–6.8 | 2.6 | 1.3–5.0 | 2.3 | 1.2–4.5 | |
| Number of blocks | 0–2 | 76/373 | 20.4 | 1.0 | – | 1.0 | – | 1.0 | – |
| 3 | 12/59 | 20.3 | 0.9 | 0.5–1.5 | 1.0 | 0.6–1.9 | 0.9 | 0.5–1.6 | |
| 4 | 8/29 | 27.6 | 1.0 | 0.6–2.0 | 1.5 | 0.7–3.0 | 1.4 | 0.8–2.5 | |
| 5 >= | 10/23 | 43.5 | 1.2 | 0.8–2.0 | 0.9 | 0.5–1.6 | 1.0 | 0.5–1.7 | |
*Participants who died during the follow-up period (n = 47) were excluded from the analysis. †RR: risk ratio. ⁑CI confidence interval. §Adjusted for age category, sex, marital status, education, drinking, smoking, BMI, vision impairment, hearing handicap, knee joint pain, depressive symptoms, and history of life-threatening diseases (stroke, coronary heart disease, diabetes mellitus, cancer). ∥In addition to the variables adjusted in Model 1, back pain and bone stiffness category are included